يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"processing phase involves"', وقت الاستعلام: 0.11s تنقيح النتائج
  1. 1

    Image2_Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database.JPEG حسب Wen-Long Xie (19842993)

    منشور في 2024
    "…</p>Methods<p>A retrospective pharmacovigilance study was conducted using FAERS data from Q1 2004 to Q4 2023. The data processing phase involved the FDA-recommended deduplication method, and ADRs were classified according to Medical Dictionary for Regulatory Activities (MedDRA). …"
  2. 2

    Table1_Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database.DOCX حسب Wen-Long Xie (19842993)

    منشور في 2024
    "…</p>Methods<p>A retrospective pharmacovigilance study was conducted using FAERS data from Q1 2004 to Q4 2023. The data processing phase involved the FDA-recommended deduplication method, and ADRs were classified according to Medical Dictionary for Regulatory Activities (MedDRA). …"
  3. 3

    Image3_Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database.JPEG حسب Wen-Long Xie (19842993)

    منشور في 2024
    "…</p>Methods<p>A retrospective pharmacovigilance study was conducted using FAERS data from Q1 2004 to Q4 2023. The data processing phase involved the FDA-recommended deduplication method, and ADRs were classified according to Medical Dictionary for Regulatory Activities (MedDRA). …"
  4. 4

    Table3_Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database.XLSX حسب Wen-Long Xie (19842993)

    منشور في 2024
    "…</p>Methods<p>A retrospective pharmacovigilance study was conducted using FAERS data from Q1 2004 to Q4 2023. The data processing phase involved the FDA-recommended deduplication method, and ADRs were classified according to Medical Dictionary for Regulatory Activities (MedDRA). …"
  5. 5

    Table2_Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database.XLSX حسب Wen-Long Xie (19842993)

    منشور في 2024
    "…</p>Methods<p>A retrospective pharmacovigilance study was conducted using FAERS data from Q1 2004 to Q4 2023. The data processing phase involved the FDA-recommended deduplication method, and ADRs were classified according to Medical Dictionary for Regulatory Activities (MedDRA). …"
  6. 6

    Image1_Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database.JPEG حسب Wen-Long Xie (19842993)

    منشور في 2024
    "…</p>Methods<p>A retrospective pharmacovigilance study was conducted using FAERS data from Q1 2004 to Q4 2023. The data processing phase involved the FDA-recommended deduplication method, and ADRs were classified according to Medical Dictionary for Regulatory Activities (MedDRA). …"